Showing results (261-270 of 268) with videos related to
Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 268 results.
Cancer|March 15, 1992
Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracilJ A Laurie, R G Hahn, T M Therneau, et al.Cancer|January 1, 1985
A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancerH W Bruckner, G E Dinse, T E Davis, et al.The Journal of Family Practice|May 1, 1988
Obstetric ultrasound training for family physicians. Results from a multi-site studyR G Hahn, L D Roi, S M Ornstein, et al.American Journal of Clinical Oncology|August 1, 1982
A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapyD L Ahmann, J R O'Fallon, P W Scanlon, et al.Lancet (London, England)|April 29, 1978
Repeated adjuvant chemotherapy with phenylalanine mustard or 5-fluorouracil, cyclophosphamide, and prednisone with or without radiation, after mastectomy for breast cancerD L Ahmann, P W Scanlon, H F Bisel, et al.The New England Journal of Medicine|January 1, 1981
Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancerJ N Ingle, D L Ahmann, S J Green, et al.Cancer|July 1, 1978
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group ReportP S Schein, P T Lavin, C G Moertel, et al.Cancer|October 15, 1981
Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study GroupC G Moertel, S Frytak, R G Hahn, et al.Pageof 27